Goldman Sachs ETF Trust. Holdings as of May 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| ELI LILLY & COMPANYLLY | 13.28% | $2.67M | 2,417 |
| JOHNSON & JOHNSONJNJ | 8.07% | $1.62M | 7,204 |
| ASTRAZENECA PLC | 4.84% | $1.31M | 5,234 |
| MERCK & COMPANY INCMRK | 5.94% | $1.20M | 10,073 |
| GUARDANT HEALTH INCGH | 5.34% | $1.07M | 8,286 |
| THERMO FISHER SCIENTIFIC INCTMO | 4.52% | $909.67K | 1,847 |
| ARGENX SEARGX | 4.07% | $818.43K | 979 |
| INTUITIVE SURGICAL INCISRG | 3.90% | $785.16K | 1,849 |
| BOSTON SCIENTIFIC CORPBSX | 3.78% | $760.40K | 15,740 |
| LONZA GROUP AG | 2.80% | $720.47K | 879 |
| EDWARDS LIFESCIENCES CORPEW | 2.98% | $600.02K | 6,939 |
| DEXCOM INCDXCM | 2.79% | $561.97K | 7,621 |
| AGILENT TECHNOLOGIES INCA | 2.77% | $556.35K | 4,105 |
| ROIVANT SCIENCES LTD | 2.39% | $480.92K | 16,036 |
| CENCORA INCCOR | 2.34% | $471.38K | 1,750 |
| APOGEE THERAPEUTICS INC | 1.97% | $396.16K | 4,823 |
| ROYALTY PHARMA PLC | 1.77% | $355.19K | 6,370 |
| PENUMBRA INCPEN | 1.61% | $323.07K | 1,015 |
| METTLER-TOLEDO INTERNATIONAL INCMTD | 1.59% | $319.94K | 271 |
| VERTEX PHARMACEUTICALS INCVRTX | 1.48% | $298.51K | 667 |
| GOLDMAN SACHS TRUSTCash or money market | 1.43% | $287.99K | 287,989 |
| GALDERMA GROUP AG | 1.10% | $282.08K | 1,034 |
| CYTOKINETICS INCCYTK | 1.40% | $281.17K | 3,663 |
| IONIS PHARMACEUTICALS INCIONS | 1.37% | $276.47K | 3,614 |
| XENON PHARMACEUTICALS INCXENE | 1.35% | $272.39K | 4,977 |
| UNITEDHEALTH GROUP INCUNH | 1.35% | $271.92K | 715 |
| REPLIGEN CORPRGEN | 1.26% | $252.61K | 2,038 |
| INSMED INCINSM | 1.11% | $222.48K | 2,081 |
| MADRIGAL PHARMACEUTICALS INCMDGL | 1.06% | $213.83K | 430 |
| REVOLUTION MEDICINES INCRVMD | 0.84% | $168.35K | 1,069 |
| CG ONCOLOGY INCCGON | 0.75% | $151.49K | 2,432 |
| BRIDGEBIO PHARMA INCBBIO | 0.73% | $146.70K | 2,214 |
| QUEST DIAGNOSTICS INCDGX | 0.72% | $144.42K | 741 |
| RHYTHM PHARMACEUTICALS INCRYTM | 0.68% | $135.84K | 1,538 |
| SARTORIUS STEDIM BIOTECH SA | 0.55% | $129.27K | 533 |
| ALKERMES PLC | 0.57% | $114.04K | 2,703 |
| PRAXIS PRECISION MEDICINES INCPRAX | 0.55% | $110.59K | 316 |
| DEFINIUM THERAPEUTICS INCDFTX | 0.51% | $101.94K | 4,214 |
| SPYRE THERAPEUTICS INCSYRE | 0.35% | $70.56K | 960 |
| INSULET CORPPODD | 0.29% | $57.69K | 398 |
| STRUCTURE THERAPEUTICS INCGPCR | 0.20% | $39.65K | 1,008 |
| HOYA CORP | 3.53% | $4.46K | 4,173 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.